According to an article coauthored by mark Cohen in the September 2021 issue of Nature Biotechnology, government planning and targets for patents in China, while boosting overall quantity, negatively impacted overall quality. Quality concerns were manifested by a clear end-of-year trough in forward citations of patents filed near year’s end.
This is the first in a series of blogs on recent research. The USPTO just released its report on Trademarks and Patents in China, The Impact of Non-Market Factors on Filing Trends […]
Along with Prof. Zhen Lei of Penn State, I have previously blogged about the late autumn surge in patent filings in China, in 2012, as well as in prior years. This autumnal […]